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ABSTRACT

An erythromycin-resistant strain of probiotic Lactobacillus paracasei ssp. paracasei LBC-1 (LBC-1e)
was added to part-skim Mozzarella cheese in alginatemicroencapsulated or free form at a level of 108 and 107
cfu/g, respectively. Survival of LBC-1e and total lactic
acid bacteria (LAB) was investigated through the pasta
filata process of cheese making (in which the cheese curd
was heated to 55°C and stretched in 70°C-hot brine),
followed by storage at 4°C for 6 wk and simulated gastric and intestinal digestion. This included incubation
in 0.1 M and 0.01 M HCl, 0.9 M H3PO4, and a simulated
intestinal juice consisting of pancreatin and bile salts
in a pH 7.4 phosphate buffer. Some reductions were
observed in both free and encapsulated LBC-1e during heating and stretching, with encapsulated LBC-1e
surviving slightly better. Changes in total LAB losses
during heating and stretching did not reach statistical
significance. During storage, a decrease was observed in
total LAB, but no statistically significant decrease was
observed in LBC-1e. Survival during gastric digestion
in HCl was dependent on the extent of neutralization
of HCl by the cheese, with more survival in the weaker
acid, in which pH increased to 4.4 after cheese addition.
The alginate microcapsules did not provide any protection against the HCl. It is interesting that survival of
the encapsulated LBC-1e was greater during incubation
in H3PO4 than in the HCl gastric juices. Proper selection of simulated gastric digestion media is important
for predicting the delivery of probiotic bacteria into the
human intestinal tract. Neither free nor encapsulated
LBC-1e was affected by incubation in the pancreatinbile solution. Based on the level of probiotic bacteria in
cheese needed to provide a health benefit and its survival during simulated gastric digestion, as determined
in this study, it should theoretically be possible to lower
the amount that needs to be ingested in cheese by up
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to a factor of 103 compared with other fermented dairy
foods or when consumed as supplements.
Key words: microencapsulation, probiotic, Mozzarella, cheese, gastric
INTRODUCTION

Probiotics are live microorganisms that, when administered in adequate amounts (106 to 107 cfu/g), confer
a health benefit on the host (FAO/WHO, 2002). Probiotics may be consumed either as a food component
or as a nonfood preparation. Foods containing such
bacteria fall within the functional foods category, and
these are described as foods claimed to have a positive
effect on health. However, for a probiotic bacterium to
provide a benefit to human health, it must fulfill several
criteria. It must have good technological properties so
that it can be manufactured and incorporated into food
products without losing viability and functionality. It
must maintain that viability through storage to the
end of the shelf life of the food and should not create
unpleasant flavors or textures. It must also survive passage through the upper gastrointestinal (GI) tract and
arrive alive at its site of action, and it must be able to
function in the gut environment (Mattila-Sandholm et
al., 2002).
Yogurts and other fermented milks have been used as
delivery systems for probiotic cultures, although cheese
has been suggested as a better carrier because of better survival of the probiotic culture during storage and
through the GI tract (Ong et al., 2006; Sharp et al.,
2008). Various cheeses have been investigated, including Cheddar (Stanton et al., 1998; Phillips et al., 2006),
low-fat Cheddar (Sharp et al., 2008), Gouda (Gomes et
al., 1998), cottage cheese (Heller, 2001), Turkish white
cheese (Kasimoglu et al., 2004), Argentinean cheese
(Bergamini et al., 2006), and Kaúar (Ozer et al., 2008).
Whether probiotic bacteria can survive in cheeses that
are exposed to a severe heat treatment (such as the
pasta filata process used during manufacture of Mozzarella cheese) has not been reported. It is also difficult
to properly enumerate probiotic bacteria in cheese by
using selective media when high numbers of other lactic
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acid bacteria (LAB) are present (Oberg et al., 2011)
unless the probiotic culture contains a biomarker that
allows its specific enumeration (Sharp et al., 2008).
The pH and reduced oxygen levels of cheese make
it suitable for long-term survival of probiotic bacteria
(Boylston et al., 2004; Phillips et al., 2006). In contrast,
lower pH and higher oxygen levels in a liquid matrix,
such as fermented milks and yogurt, may not maintain
sufficient numbers (i.e., >107 viable cell/g) of the probiotic bacteria (such as some strains of Bifidobacterium
spp.) through to the end of the shelf life (Gardiner et
al., 1999; Shah, 2000). It has also been suggested that
the high buffering capacity and lipid content of cheese
provide protection to probiotic bacteria in the GI tract
(Phillips et al., 2006). Thus, cheese could deliver viable
probiotics in sufficient numbers to provide therapeutic
effects through the entire shelf life (Burns et al., 2008).
To exert a health benefit via action in the distal
ileum and colon, probiotic bacteria must survive passage through the esophagus, a highly acidic stomach,
and an alkaline small intestine (Naidu et al., 1999).
Losses of up to 6 to 9 log cfu/g of probiotic bacteria in simulated gastric digestion have been reported
(Sabikhi et al., 2010; Ortakci, 2010), depending on the
bacterial strain and testing conditions. Immobilization
of bacteria within an encapsulating matrix has been
investigated as a means of reducing cell injury or loss
and improving their survival in foods (Kailasapathy,
2006; Muthukumarasamy and Holley, 2006; Ozer et al.,
2009; Ortakci, 2010; Brinques and Ayub, 2011) and
during gastric digestion (Chandramouli et al., 2004; Picot and Lacroix, 2004; Muthukumarasamy et al., 2006;
Ding and Shah, 2009; Pimentel-González et al., 2009;
Ortakci, 2010; Brinques and Ayub, 2011).
To be effective, capsules should maintain integrity in
the foodstuff and during digestion and passage though
the GI tract, after which they should break down and
release their contents. Different types of encapsulating
materials have been used to trap probiotic bacteria. The
most common is alginate because it has the benefits of
being nontoxic, easy to form into a gel, and readily
available (Ding and Shah, 2009). Mixing an aqueous
Na-alginate-bacterial suspension with vegetable oil can
create a water-in-oil emulsion that, when treated with
Ca, solidifies into beads (Sheu and Marshall, 1993) of
0.025 to 2 mm in diameter, depending on shear rate
(Krasaekoopt et al., 2003).
Reports have been conflicting on the effectiveness of
alginate encapsulation of probiotic bacteria to increase
survival in simulated gastric juice (SGJ). Hansen et al.
(2002) found no improvement in the survival of acidsensitive bifidobacteria incubated in SGJ at pH 2, 4,
or 6 when using alginate microspheres with diameters
of <100 μm. Krasaekoopt et al. (2004) also reported
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no increased survival of alginate-encapsulated Bifidobacterium bifidum in HCl-SGJ at pH 1.55. In contrast,
Muthukumarasamy et al. (2006), who encapsulated 5
different strains of Lactobacillus reuteri in 2% alginate
using small (~40-μm) or large (~2-mm) capsules, reported a protective effect in SGJ at pH 1.5 (0.08 M
HCl, 0.2% NaCl). Using the same SGJ, Ortakci (2010)
observed a similar effect with ~2-mm alginate capsules
containing Lactobacillus acidophilus ATCC 4356, with
a ~3-log reduction in encapsulated bacteria compared
with no survival (>7-log reduction) of free Lb. acidophilus ATCC 4356 under the same conditions.
This study investigated the survival of the probiotic
Lactobacillus paracasei during the manufacture and
storage of low-moisture part-skim Mozzarella cheese,
and whether encapsulating the bacteria in alginate
microcapsules would increase their survival. Some question remains regarding whether the reported benefits
of using cheese to deliver probiotic cultures is an inherent function of the cheese or a consequence of how
survival in the human digestive tract is simulated and
measured. To elucidate such survival using cheese as a
delivery mechanism, the cheese was added to simulated
gastric juice of various acidic conditions (and a simulated intestinal juice) and then bacterial survival was
measured.
MATERIALS AND METHODS
Materials

Lactobacillus paracasei ssp. paracasei LBC-1e, an
erythromycin-resistant derivate (Broadbent et al.,
2004) of the probiotic strain LBC-1 (Cargill, Waukesha, WI), was obtained from the culture collection
of Jeffrey Broadbent (Utah State University, Logan).
Streptococcus thermophilus starter culture TS-10C was
donated by DSM Food Specialties USA Inc. (Eagleville,
PA). Sodium alginate, Tween-80, erythromycin, and
bile salts were purchased from Sigma-Aldrich Co. (St.
Louis, MO); Elliker’s agar, de Man, Rogosa, and Sharpe
(MRS) broth, and agar were from Becton Dickinson
(Franklin Lakes, NJ); peptone was from EMD Chemicals Inc. (Gibbstown, NJ); pepsin was from Mallinckrodt Baker Inc. (Phillipsburg, NJ); pancreatin was from
Spectrum Chemical Mfg. Co. (New Brunswick, NJ);
and corn oil (Western Family Foods Inc., Portland, OR)
was from a local supermarket. The CaCl2·H2O, HCl,
NaCl, NaH2PO4, and Na2HPO4 were analytical reagent
grade. Double-strength chymosin rennet (Maxiren) was
from DSM Food Specialties USA Inc., and fluorescein
isothiocyanate (FITC) was from Sigma-Aldrich Co.
The SYTO 9 used was a component of a LIVE/DEAD
BacLight bacterial viability kit (Invitrogen, Carlsbad,
Journal of Dairy Science Vol. 95 No. 11, 2012
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CA). Microscope slides were from Mercedes Medical
(Sarasota, FL), and the Taylor Lube petroleum gel was
from Haynes Manufacturing Co. (Westlake, OH).
Bacterial Growth Conditions

Working cultures of LBC-1e were prepared from frozen stocks stored at −70°C by sequential transfer twice
into MRS broth containing 3 μg/mL of erythromycin,
in which the cultures were incubated anaerobically at
37°C for 18 h. After incubation overnight, the media
containing cells were centrifuged at 4,250 × g for 10
min at 4°C, following which the supernatant was removed and the cells were further washed twice (4,250 ×
g for 10 min at 4°C) with sterile 0.1% (wt/vol) peptone
water. The washed cells were suspended to ~1010 cfu/
mL in saline-peptone water by comparing the optical
density with a previously prepared standard curve (R2
≥ 0.9; data not shown).
Microencapsulation

Bacterial cells were microencapsulated in alginate by
the modified emulsion method of Sheu and Marshall
(1993). Briefly, 200 mL of cell suspension (~1010 cfu/
mL) was mixed with 800 g of a 25 g/kg Na-alginate
solution with continuous stirring at 400 rpm for 10 min
to entrap bacteria. The alginate-culture mixture was
then added dropwise through a 50-mL sterile syringe
fitted with a needle into 5 kg of corn oil containing
0.2% (wt/vol) Tween-80 with stirring (~500 rpm).
When the oil-alginate mixture formed an emulsion, as
was evident from the increasing turbidity, a sterile 0.2
M CaCl2 solution was added immediately to polymerize the alginate and break the emulsion. After 30 min,
the Ca-alginate microcapsules formed were collected by
vacuum filtration through Whatman #4 filter paper
(Whatman International, Maidstone, UK), washed
twice in 0.2 M CaCl2, and then stored in peptone-saline
solution at 4°C until use.

ther 10 g of broth containing free LBC-1e cells (~1 ×
1010 cfu/g) or 360 g of encapsulated LBC-1e (~5 × 108
cfu/g). The milk was stirred and then allowed to coagulate. After 15 min, the curd was cut using wire knives
(16-mm spacing), healed for 10 min, and then stirred
and heated to 41°C. With continued stirring, one-third
portions of whey were removed after 15 and 35 min,
and the whey was drained down to the curd level after
a further 10 min. The curd was stirred for 10 min and
washed with 13°C water to cool the curd to 22°C; it was
then drained and salted at 10 g/kg.
Each batch of curd (containing either free or encapsulated LBC-1e) was divided into three 550-g portions,
and a sample was collected for bacterial enumeration.
Each replicate portion of curd was stretched in an excess amount of hot 70°C brine (containing 50 g/kg of
NaCl) for about 1 min to heat the curd to 55 ± 1°C
and held for 2 min. The hot cheese was then placed
in a stainless steel mold and immersed in iced brine
(containing 50 g/kg of NaCl and 3 g/kg of CaCl2) for
2 h. The temperature of the cheese blocks decreased
to ~24°C in 30 min, ~12°C after 1 h, and to 6°C by
2 h. Each block of cold cheese was sampled for bacterial enumeration, and then cut into 4 pieces, vacuumed
packaged, and stored at 4°C.
Bacterial Enumeration

Bacteria were enumerated from Mozzarella cheese
containing free LBC-1e after mixing 25 g of cheese
with 225 mL of 0.1% peptone water at 230 rpm for
10 min (Model 400 stomacher; Seward, London, UK).
For cheese containing encapsulated LBC-1e, 0.2 M
phosphate buffer (pH 7) was used in place of peptone
water to disrupt the alginate gel and release the encapsulated bacteria. Total LAB were enumerated on MRS
agar with the pour-plate method and were incubated
anaerobically at 37°C for 48 h. The LBC-1e was selectively enumerated on MRS agar containing 3 μg/mL of
erythromycin.

Mozzarella Cheese Manufacture

Simulated Gastric Digestive

Fresh bovine milk was obtained from Utah State University’s George B. Caine Dairy Research and Teaching Center (Wellsville, UT) and was standardized to
a protein:fat ratio of 1.2 and pasteurized at 73°C for
15 s in the Gary Haight Richardson Dairy Products
Laboratory. Two 16-kg portions of milk were warmed
to 35°C in small stainless steel vessels, 1 g of starter
culture was added to each, and the milk was ripened
for 60 min. The milk was then renneted by adding 4
mL of chymosin. The milk was stirred for ~2 min, and
the adjunct probiotic culture was quickly added as ei-

To investigate the influence of pH on the survival of
probiotic bacteria, sterile filtered SGJ (based on that
used by Mainville et al., 2005) containing 2.0 g/kg of
NaCl and 0.3 g/kg of pepsin was prepared using HCl.
To provide pH of the SGJ-cheese mixture similar to
the physiological pH of the human stomach (~pH 1.4),
SGJ-1 was made using 0.1 M HCl with a cheese:SGJ
ratio of 1:6. For SGJ-2, the same acid concentration
was used but the cheese:SGL ratio was changed to 1:4,
and then to simulate physiological conditions in which
further acid is secreted into the stomach after food in-

Journal of Dairy Science Vol. 95 No. 11, 2012

MICROENCAPSULATED PROBIOTICS IN MOZZARELLA

gestion, additional HCl was added during incubation of
the SGJ-cheese mixture to maintain pH <3. To further
test the effect of pH on bacterial survival and allow a
greater increase in pH after adding the cheese, SGJ-3
was then made using 11 mM HCl. An additional acid
digestion test (SGJ-4) was performed using 87 mM
H3PO4 (pH 2.0) instead of HCl as a comparison with
the report of Sharp et al. (2008) [Sharp et al. (2008)
incorrectly reported the strength of the H3PO4 they
used as 8.7 mM.] Before adding cheese, the SGJ were
tempered to 37°C. The mixture was then stomached for
10 min at 230 rpm and held at 37°C for up to 2 h with
periodic shaking.
Simulated Intestinal Digestive

After treating the cheese for 60 min in 0.1 M HCl
(SGJ-1), the mixture was converted to simulated intestinal juice (SIJ; Huang and Adams, 2004; Annan
et al., 2008) by adding to 36 mL of the mixture 1 mg/
mL pancreatin and 4.5 g/mL of bile salts suspended in
phosphate buffer, and then adjusting to pH 7.4 with 0.1
M NaOH. The cheese-SIJ mixture was then incubated
for 4 h at 37°C with periodic shaking.

6277

encapsulation as the treatment effect with 3 replicates.
Significance was declared at P ≤ 0.05.
RESULTS AND DISCUSSION
Cheese Composition

The cheeses had similar moisture of 55.5 and 55.6%
and pH of 5.39 and 5.41, respectively, for cheese containing free or encapsulated bacteria. A slightly lower
fat content (12.5 vs. 15.8%) and higher salt content
(1.88 vs. 1.70%) were observed (P < 0.05) for the
cheese with the encapsulated bacteria. These differences were not expected to influence bacterial survival
and were assumed to relate to the presence of the alginate microcapsules during milk coagulation and curd
manufacture.
As shown in Figure 1, the microcapsules containing
the LBC-1e bacteria (A) were located in the serum
and fat pockets that form within the curd structure
as the protein matrix forms and that contract as a
consequence of renneting, acid development and curd
agitation, and cooking. During the hot-water stretching
process, the fat droplets are then oriented into channels
concomitantly with the protein matrix forming into
fibrous strands (Oberg et al., 1993).

Microstructure

Thin slices (~10 × 10 × 3 mm) of Mozzarella cheese
mounted on microscope slides were treated with 5 g/L
of FITC in an acetone:water (1:1) solution to stain for
protein. The sample was rinsed twice with water and
then treated with 3.34 mM of the SYTO 9 fluorophore.
Stained samples were mounted on standard microscope
slides with glycerin jelly and then examined using an
inverted laser scanning confocal microscope (BioRad,
Hercules, CA) with an Ar/Kr laser that provided excitation of both FITC and SYTO 9 at a wavelength of
488 nm. Emissions from the fluorophores were captured
sequentially using filters of wavelengths 512 to 532 nm
for SYTO 9 and ≥585 nm for FITC.
Statistical Analysis

Logarithmic reductions in bacterial numbers as a
consequence of hot water stretching and chemical
analysis results of both cheese samples were analyzed
by one-way ANOVA and Tukey’s multiple comparison
test (PROC GLIMMIX; SAS Institute Inc., Cary, NC)
with 3 replicates. Logarithmic reductions in bacterial
numbers during storage and as a consequence of SGJ
or SIJ incubation were analyzed using repeated measurement and Tukey’s multiple comparison test (PROC
GLIMMIX; SAS Institute Inc.) as a 2-way factorial with

Cheese Manufacture and Storage

Initial numbers of total LAB in the cheese curd were
8.3 × 108 and 2.2 × 109 cfu/g for curds that contained
free and encapsulated bacteria, respectively (Table 1).
Included in this enumeration were the St. thermophilus
starter culture and the LBC-1e probiotic culture. Addition of LBC-1e to milk had been planned to provide
about 1 × 109 cfu/g of bacteria per 28-g serving of
cheese, assuming the concentration of bacteria would
be 10-fold during conversion of milk into curd, with an
allowance for potential loss of microcapsules by sedimentation before coagulation. The number of LBC-1e
added to the milk had been estimated at ~6 × 106
and ~1 × 107 cfu/g of free and encapsulated bacteria,
respectively, and the amount measured in the cheese
curd was 6.6 × 107 and 5.4 × 108 cfu/g, respectively.
Thus, less loss of encapsulated bacteria occurred during
the coagulation process than anticipated, and the 2 sets
of cheese curd contained above the target of 3.61 × 107
cfu/g.
When the curd was immersed and stretched in hot
water, the bacterial numbers decreased slightly (Table
1). Total LAB had mean log reductions of 0.20 and
0.40 for the control and encapsulated treatments, respectively. The extent of decrease for total LAB was
not significantly different (P = 0.095) in the control
Journal of Dairy Science Vol. 95 No. 11, 2012
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Table 1. Mean microbiological counts (cfu/g) for total lactic acid bacteria (LAB) and added Lactobacillus
paracasei LBC-1e (LBC-1e) in Mozzarella curd (before hot stretching) and cheese during refrigerated storage
for cheese in which LBC-1e was added to milk before renneting as free (control) or alginate-encapsulated
bacteria1
Total LAB
Time (d)
2

0 (curd)
03 (cheese)
7
21
42

Control
8.19
5.00
6.61
2.24
2.23

×
×
×
×
×

LBC-1e

Encapsulated
8

10
108
108
108
108

1.78
6.62
1.82
7.38
7.13

×
×
×
×
×

9

10
108
109
108
108

Control
5.98
2.11
2.46
3.75
3.18

×
×
×
×
×

Encapsulated
7

10
107
107
107
107

5.37
3.16
3.44
2.55
2.50

×
×
×
×
×

108
108
108
108
108

1

The total LAB includes the Streptococcus thermophilus starter culture, free or encapsulated LBC-1e, respectively, and any nonstarter LAB present in the cheese.
2
Before the hot stretching process of curd.
3
After the hot stretching process of curd.

cheese but was in the cheese containing the encapsulated bacteria. The survival of encapsulated LBC-1e
bacteria was slightly higher (P = 0.012) than that in
cheese containing free bacteria, with log reductions of
0.25 and 0.45, respectively.
During 42-d storage, no decrease (P = 0.84) was
observed in the number of either free or encapsulated
LBC-1e (Table 1) in the Mozzarella cheese, as has been

Figure 1. Laser scanning confocal micrograph of Mozzarella cheese
containing alginate-encapsulated Lactobacillus paracasei LBC-1e
with protein imaged using fluorescein isothiocyanate (Sigma-Aldrich
Inc., Saint Louis, MO; gray), bacterial cells imaged using SYTO 9
(Invitrogen, Carlsbad, CA; white), and serum pockets and fat not being stained (black). A: Microcapsule containing LBC-1e located in a
serum pocket; B: Streptococcus thermophilus starter culture distributed
throughout the protein matrix.
Journal of Dairy Science Vol. 95 No. 11, 2012

shown for Cheddar cheese storage (Stanton et al., 1998;
Gardiner et al., 1999; Sharp et al., 2008). However, the
total LAB numbers decreased significantly (P < 0.0001)
during the storage period, indicating that a slow die-off
of residual starter St. thermophilus bacteria occurred
after the first week of refrigerated storage.
Simulated Gastric Digestion

The extent of die-off of bacteria when the cheese was
incubated in HCl-based SGJ was a function of both
acid concentration and the extent of neutralization of
acid upon cheese addition. When cheese was incubated
in SGJ-1 (0.1M HCl, pH 0.65, cheese:SGJ ratio of 1:6),
the LBC-1e numbers decreased by 4.2 log after a 60-min
incubation (Table 2). Initial mean bacteria counts were
5.6 × 107 and 3.5 × 108 cfu/g for free and encapsulated
LBC-1e, and after 1 h they had declined to 4.7 × 103
and 2.7 × 104 cfu/g, respectively (P < 0.0001).
After adding the cheese, the pH of the mixture had
increased to pH 1.4, which is similar to the pH of the
human stomach before ingestion of food. In such a harsh
environment, no protection was provided by encapsulation of the bacteria in Ca-alginate. This agrees with
the reports of Hansen et al. (2002) and Krasaekoopt
et al. (2004) rather than that of Muthukumarasamy et
al. (2006). Because protection has been observed when
using large macrocapsules (Ortakci, 2010), it appears
that size of the capsules influences the protective effect
of alginate encapsulation. It may be that in larger (~2mm) capsules, a die-off of bacteria occurs in the outer
regions, which are more exposed to the acid, whereas
the bacteria in the inner regions are protected. This
would explain the ~3-log reduction observed in macroencapsulated Lb. acidophilus while free bacteria showed
no survival (>7-log loss; Ortakci, 2010).
When a greater proportion of cheese was added (such
as in SGJ-2), the pH of the cheese-SGJ mixture in-
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Table 2. Mean loss (n = 3) of free (control) and encapsulated Lactobacillus paracasei LBC-1e in Mozzarella cheese after incubation in simulated
gastric juice (SGJ) and simulated intestinal juice (SIJ)
pH
Juice
SGJ-1
SGJ-2
SGJ-3
SGJ-4
SIJ3

Composition
0.1M HCl
0.1M HCl2
0.01M HCl
0.9M H3PO4
Bile and pancreatin

Ratio1
1:6
1:4
1:6
1:9
1:6

Time (min)
60
120
120
120
240

Initial
0.65
0.65
1.5
2.0
7.4

Loss during incubation (log10 cfu/g)
Final
1.4
2.3
4.4
2.2
7.4

Control
a,x

3.77
1.88b,x
1.03c,x
3.80a,y
0d,x

Encapsulated
4.20a,x
1.50b,x
1.13b,x
1.05b,x
0c,x

a–d

Means within a column with the same letters are not significantly different (α = 0.05).
Means within a row with the same letters are not significantly different (α = 0.05).
1
Ratio of cheese added to simulated gastric solutions.
2
Additional 0.1M HCl was added to SGJ-2 during incubation to maintain pH <2.5.
3
Survival in SIJ was determined by adding 1 mg/mL of pancreatin and 4.5 g/mL of bile salts suspended in phosphate buffer after incubating
cheese in SGJ-1 for 60 min, then adjusting pH to 7.4 with 0.1 M NaOH.
x,y

creased above that maintained in the stomach, primarily because of the buffering capacity of the protein and
phosphate in the cheese. By periodically adding 0.1 M
HCl during incubation, this buffering effect was countered and the final pH of SGJ-2 was 2.3. Under these
conditions, survival of bacteria was greater compared
with that in SGJ-1, and numbers of free and encapsulated LBC-1e in SGJ-2 decreased from initial mean
values of 1.5 × 107 and 2.6 × 108 cfu/g to 1.5 × 105
and 1.1 × 107 cfu/g, respectively, after a 2-h incubation
(P < 0.0001). Again, no protection was observed on
bacterial survival in SGJ-2 provided by encapsulation.
The loss of bacteria after a 2-h incubation in 11 mM
HCl (SGJ-3) was minimal, with 90% of LBC-1e surviving (i.e., only ~1-log reduction) for both free and
encapsulated bacteria. Initial mean counts were 3.29
× 107 and 2.55 × 108 cfu/g for free and encapsulated
bacteria, respectively, and these had declined to 3.14 ×
106 and 1.08 × 107 cfu/g after incubation (P < 0.0001).
Such survival can be attributed to buffering of SGJ3 by the cheese, and it was observed that pH of this
gastric solution increased to pH ≥4 within 2 min. This
supports the notion that the matrix in which the bacteria are present can influence their survival, as shown
by Sharp et al. (2008), and that bacteria, as a liquid
culture, are not protected as effectively as when present
in a semisolid matrix. This explains why Gardiner et
al. (1999) found no reduction in probiotic bacteria in
Cheddar cheese after a 2-h incubation in porcine gastric
juice that had an initial pH of 2.0 and a final pH of
4.74. It is important in such simulated testing that the
SGJ match the proper physiological conditions because
bacterial survival is influenced by the pH (Mainville
et al., 2005; Pitino et al., 2010) encountered by the
probiotic bacteria when ingested.
We have shown that the buffering effect of a food that
is delivering probiotic bacteria can influence bacterial

survival when tested in vitro using an acid medium
to simulate gastric contents of the human stomach.
However, such buffering provides an artifactual result
because in vivo in a healthy individual, additional acid
is secreted into the stomach to maintain acidity at or
below ~pH 2. Under such conditions, a 4-log reduction in bacterial numbers can be expected in foods with
greater reductions occurring when bacteria are ingested
in a nonprotected form.
When acid tolerance of LBC-1e was tested using
phosphoric acid (SGJ-4) so that buffering effects of
the cheese would be negated, bacteria again had very
poor survival (P < 0.0001) in the control Mozzarella
cheese containing free LBC-1e. The pH of SGJ-4 remained ~2 during incubation, and mean numbers of
free LBC-1e fell from an initial level of 3.3 × 107 cfu/g
to 2.0 × 103 cfu/g after incubation (P < 0.0001; Table
2). This agrees with the report of Sharp et al. (2008),
who observed a 3.8-log reduction after a 2-h incubation in SGJ-4 of a low-fat Cheddar cheese containing
Lb. paracasei 334e. It is interesting that greater survival was observed when the bacteria were present in
cheese in encapsulated form (Table 2). Mean numbers
of LBC-1e were 2.6 × 108 cfu/g before incubation and
remained at 2.3 × 107 cfu/g after the 2-h incubation
(P < 0.0001).
The in vitro test of gastric survival using H3PO4
(SGJ-4) was useful to provide a buffering effect when
the bacteria were present in a free form, but it was not
a good test for acid tolerance of the bacteria in the
alginate microcapsules. Some interaction between the
H3PO4 and Ca-alginate capsules possibly may have prevented penetration of acid into the capsules. As shown
in SGJ-2, in which HCl was replenished during incubation so as to maintain acid conditions of the cheeseSGJ mixture, encapsulation was unable to provide any
significant protective effect for the bacteria.
Journal of Dairy Science Vol. 95 No. 11, 2012
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When the cheese-SGJ-1 mixture was neutralized and
bile and pancreatin were added to form SIJ, a slight
increase in bacterial numbers to 4.7 × 103 and 2.7 ×
104 cfu/g was observed for the free and encapsulated
bacteria, respectively, probably because of resuscitation
of some cells that were sublethally injured during the
1-h incubation of SGJ-1. Incubation of the cheese-SIJ
mixture for 4 h at 37°C did not significantly affect
survival of either free or encapsulated LBC-1e (Table
2), indicating a natural bile resistance of this probiotic
strain.
In the present study, using cheese as a delivery system has a positive effect on survivability of the bacteria
because of its buffering effect and possibly because it
may provide a protective environment to the probiotic
bacteria (Ruass-Madiedo et al., 2002). Compared with
yogurt and other fermented milks, the higher buffering capacity of the cheese, the higher fat content, and
the tight matrix may improve the survival of bacteria
in the stomach and intestines (Heller, 2001). It is well
known that ingesting bacteria that have been incorporated into food improves their viability during GI passage (Zárate et al., 2000; Huang and Adams, 2004). We
agree with Mainville et al. (2005) on the importance of
incorporating bacteria into a food matrix so that the
bacteria can be protected from the harsh environment
of the human digestive tract and reach their site of
action in sufficiently high numbers.
The Food and Agriculture Organization of the
United Nations/World Health Organization (FAO/
WHO, 2002) has made a general recommendation that
a probiotic food should contain 106 to 107 cfu/g so that
a 100-g serving would provide 108 to 109 cfu that were
ingested. However, dose-response studies supporting
this number are sparse; the number of probiotic bacteria that would ensure an effect has not been standardized, and this number is actually strain and effect
dependent (Rowland et al., 2010). With ingestion of
109 cfu of probiotic bacteria as an isolated culture, no
survival after passage through the stomach would be
expected, and perhaps only 102 cfu would be expected
in a liquid or soft-gel food, such as yogurt (Sharp et
al., 2008), when the pH is held constant during incubation in SGJ. If the probiotic culture is delivered in a
hard gel, such as cheese, the expected survival after
gastric passage would be 105. Thus, by having 109 cfu/
serving of a probiotic organism in cheese, 100- to 1,000fold more living cells of the bacteria would survive
in the intestinal tract, where it needs to be present
to have any beneficial health effect. If the aim is to
deliver 104 bacteria/g to the intestines, this could be
achieved beginning with as little as 106 cfu/g in cheese
because only a 2-log reduction during simulated gastric
digestion occurred when pH was maintained similarly
Journal of Dairy Science Vol. 95 No. 11, 2012

to physiological conditions and some buffering occurs.
This would have a dramatic effect on reducing the cost
of producing probiotic foods.
CONCLUSIONS

Hot stretching during Mozzarella cheese manufacture
caused slight log reductions of 0.4 and 0.2 in the numbers of free and encapsulated Lb. paracasei LBC-1e,
respectively. Refrigerated storage did not make any
difference in the numbers of free and gel encapsulated
LBC-1e; however, during storage, the total LAB numbers in both cheeses (predominantly the starter St.
thermophilus bacteria) decreased significantly. Encapsulation did not increase the survival in SGJ containing
HCl. Survival of LBC-1e was dependent on pH of the
SGJ-cheese mixture. We observed mean log reductions
of 4.0, 1.5, and 1.1 when the final pH of SGJ reached
pH 1.4, 2.3, and 4.4, respectively. This shows the importance of selecting the proper conditions for simulating
gastric digestion and when comparing various research
results using SGJ. It was unexpected that alginate encapsulation increased the survival of LBC-1e in H3PO4
SGJ, although the reason for this is not known.
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